Randomised trial of a web-based intervention for adherence in cystic fibrosis

Not Applicable

Completed

• Conditions: Cystic fibrosis; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN37959826
• Lead Sponsor: eeds Teaching Hospitals Trust (UK)

Brief Summary

2019 Abstract results in https://doi.org/10.1002/ppul.22495 number 697, page 420 (added 28/10/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-11-11
• Study Completion: 2018-02-01
• Last Update Posted: 7 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 99

Inclusion Criteria

1. Patients with a diagnosis of CF, attending Leeds Adult CF unit for their complete care
2. Male or female patients age 16 - 60 years old
3. Consecutive volunteers recruited at time of clinical stability [end of in-patient treatment or at out-patient clinic]
4. Patient must be prescribed a minimum of three specified medications (see below) for at least 6 months prior to signing the informed consent form: azithromycin hypertonic saline, TOBI®, Pulmozyme®, pancreatic enzyme replacement therapy, oral antibiotics, fat-soluble vitamins, insulin, inhaled compounded tobramycin, oral nutritional supplements, insulin, AZLI

Exclusion Criteria

1. Pregnancy
2. Acceptance on the lung transplant list (note: participation in this study will not delay or exclude patients from being placed on the transplant list in the future or receiving a transplant once enrolled in the study)

Study & Design

• Study Type: Interventional
• Study Design: Not specified